LT - CRYSTALLINE (2S)-3-[(3S,4S)-3-[(1R)-1-HYDROXYETHYL]-4-(4-METHOXY-3-{[1-(5-METHYLPYRIDIN-2-YL)AZETIDIN-3-YL]OXY}PHENYL) -3-METHYLPYRROLIDIN-1-YL]-3-OXOPROPANE-1,2-DIOL
EN - CRYSTALLINE (2S)-3-[(3S,4S)-3-[(1R)-1-HYDROXYETHYL]-4-(4-METHOXY-3-{[1-(5-METHYLPYRIDIN-2-YL)AZETIDIN-3-YL]OXY}PHENYL) -3-METHYLPYRROLIDIN-1-YL]-3-OXOPROPANE-1,2-DIOL
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
C07D 401/14 |
|
|
|
A61K 31/4439 |
|
|
|
A61P 13/10 |
|
European patent
| (11) |
Number of the document |
3189044 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
15762875.1 |
|
Date of filing the European patent application |
2015-08-28 |
| (97) |
Date of publication of the European application |
2017-07-12 |
| (45) |
Date of publication and mention of the grant of the patent |
2018-08-01
|
| (46) |
Date of publication of the claims translation |
|
PCT application
| (86) |
Number |
PCT/US2015/047415 |
|
Date |
2015-08-28 |
PCT application publication
| (87) |
Number |
WO 2016/036596 |
|
Date |
2016-03-10 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
PCT/CN2014/0859 |
2014-09-04
|
WO |
Inventors
| (72) |
HUANG, Ping, US
RIBE, Seth Dietrich, US
|
Grantee
| (73) |
Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
Title
| (54) |
CRYSTALLINE (2S)-3-[(3S,4S)-3-[(1R)-1-HYDROXYETHYL]-4-(4-METHOXY-3-{[1-(5-METHYLPYRIDIN-2-YL)AZETIDIN-3-YL]OXY}PHENYL) -3-METHYLPYRROLIDIN-1-YL]-3-OXOPROPANE-1,2-DIOL |
| |
CRYSTALLINE (2S)-3-[(3S,4S)-3-[(1R)-1-HYDROXYETHYL]-4-(4-METHOXY-3-{[1-(5-METHYLPYRIDIN-2-YL)AZETIDIN-3-YL]OXY}PHENYL) -3-METHYLPYRROLIDIN-1-YL]-3-OXOPROPANE-1,2-DIOL |
